We're delighted to add our latest Educational Series titled: MESILICO: airway remodelling in patients with severe asthma and an eosinophilic phenotype.
This Educational Review discusses MESILICO, a multicentre investigation conducted across eight pulmonology departments in Greece which evaluated the impact of mepolizumab on airway remodelling in patients with severe eosinophilic asthma.
It also includes guiding commentary from Professor Greg King, a clinician-researcher and Research Leader of the Airway Physiology and Imaging Group at the Woolcock Institute of Medical Research. He serves as a Staff Specialist, and Head of the Department of Respiratory and Sleep Medicine at Royal North Shore Hospital.
Please login below to download this issue (PDF)